A recent study analyzed the health data of 99 million patients across 8 countries, finding that numerous adverse side effects are linked to the COVID-19 vaccine.
Countries involved in the study included Argentina, Australia New South Wales, Australia – Victoria, Canada – British Columbia, Canada – Ontario, Denmark, Finland, France, New Zealand, and Scotland.
The study confirms numerous other conclusions that the vaccine is linked to conditions such as myocarditis, pericarditis, Guillain-Barré syndrome, and other health concerns.
Researchers drew data from the Global COVID Vaccine Safety (GCoVS) Project, accessing medical records to compare the health of individuals prior to and post-COVID-19 vaccination.
“This multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” the researchers wrote. “Other potential safety signals that require further investigation were identified.”
While the study focuses on vaccine side effects outside of the United States, the U.S. Centers for Disease Control and Prevention (CDC) recently released reports of injuries linked to the vaccine.
Many of the reports discussed metallic sensations in the mouth, soreness, and periods of anxiety following the inoculation. Others said they felt lightheaded and experienced tightness in their chest.
“After injection I became extremely flushed from the waist up, tachycardic with heart rate 140s, hypertensive. I also had lightheadedness and intermittent tingling in bilateral hands and lightheadedness,” one person wrote.
“Lightheadedness; vision is off, like unfocused, tingling all over body, including upper arms and legs, and thinking is slower and problems with focus and recall memory, vague headache,” another said.
